Skip to content
Business Times – Lifestyle
Author:
AnaCardio
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
June 25, 2026